ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-47

Results: 1-25/47

STUDI CLINICI CONTROLLATI E NUOVI PSICOFARMACI: ALCUNE CONSIDERAZIONI DI METODO

Authors: BARBUI C GARATTINI S

Citation: C. Barbui et S. Garattini, STUDI CLINICI CONTROLLATI E NUOVI PSICOFARMACI: ALCUNE CONSIDERAZIONI DI METODO, Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali Archivio italiano per le malattie nervose e mentali. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali , CXXIII(1), 1999, pp. 1-9

THE DRUG MARKET IN 4 EUROPEAN COUNTRIES

Authors: GARATTINI S

Citation: S. Garattini, THE DRUG MARKET IN 4 EUROPEAN COUNTRIES, PharmacoEconomics, 14, 1998, pp. 69-79

DISCREPANCY REMAINS IN PHARMACEUTICAL PRESCRIPTIONS IN 4 EUROPEAN COUNTRIES

Authors: GARATTINI S GARATTINI L

Citation: S. Garattini et L. Garattini, DISCREPANCY REMAINS IN PHARMACEUTICAL PRESCRIPTIONS IN 4 EUROPEAN COUNTRIES, BMJ. British medical journal, 317(7163), 1998, pp. 947-947

FOR A CULTURAL-CHANGE IN DRUG PRESCRIPTIONS IN GASTROENTEROLOGY

Authors: GARATTINI S

Citation: S. Garattini, FOR A CULTURAL-CHANGE IN DRUG PRESCRIPTIONS IN GASTROENTEROLOGY, The Italian Journal of Gastroenterology, 30(1), 1998, pp. 1-4

HOW TO IMPROVE MEDICAL INFORMATION ON DRUGS

Authors: GARATTINI S

Citation: S. Garattini, HOW TO IMPROVE MEDICAL INFORMATION ON DRUGS, Lancet, 352(9122), 1998, pp. 151-152

ANTIDEPRESSANT AGENTS - FROM TRICYCLICS TO SEROTONIN UPTAKE INHIBITORS

Authors: GARATTINI S BARBUI C SARACENO B

Citation: S. Garattini et al., ANTIDEPRESSANT AGENTS - FROM TRICYCLICS TO SEROTONIN UPTAKE INHIBITORS, Psychological medicine, 28(5), 1998, pp. 1169-1178

ARE ME-TOO DRUGS JUSTIFIED

Authors: GARATTINI S

Citation: S. Garattini, ARE ME-TOO DRUGS JUSTIFIED, JN. Journal of nephrology, 10(6), 1997, pp. 283-294

DRUG-METABOLISM - FROM EXPERIMENTS TO REGULATORY ASPECTS

Authors: GARATTINI S

Citation: S. Garattini, DRUG-METABOLISM - FROM EXPERIMENTS TO REGULATORY ASPECTS, Drug metabolism reviews, 29(3), 1997, pp. 853-886

PHARMACOLOGY OF AMINEPTINE, AN ANTIDEPRESSANT AGENT ACTING ON THE DOPAMINERGIC SYSTEM - A REVIEW

Authors: GARATTINI S

Citation: S. Garattini, PHARMACOLOGY OF AMINEPTINE, AN ANTIDEPRESSANT AGENT ACTING ON THE DOPAMINERGIC SYSTEM - A REVIEW, International clinical psychopharmacology, 12, 1997, pp. 15-19

TRYPTOPHAN AND DEPRESSION

Authors: BARBUI C GARATTINI S

Citation: C. Barbui et S. Garattini, TRYPTOPHAN AND DEPRESSION, Lancet, 349(9064), 1997, pp. 1553-1553

REDUCED USE OF LABORATORY-ANIMALS IN RESEARCH-INSTITUTE

Authors: GUAITANI A DEFRANCESCO L GARATTINI S

Citation: A. Guaitani et al., REDUCED USE OF LABORATORY-ANIMALS IN RESEARCH-INSTITUTE, Lancet, 349(9064), 1997, pp. 1557-1558

LIFELINE - GARATTINI,SILVIO

Authors: GARATTINI S

Citation: S. Garattini, LIFELINE - GARATTINI,SILVIO, Lancet, 349(9049), 1997, pp. 442-442

NEUROPHARMACOLOGICAL EFFECTS OF LOW AND HIGH-DOSES OF REPEATED ORAL DEXFENFLURAMINE IN RATS - A COMPARISON WITH FLUOXETINE

Authors: CACCIA S CONFALONIERI S BERGAMI A FRACASSO C ANELLI M GARATTINI S

Citation: S. Caccia et al., NEUROPHARMACOLOGICAL EFFECTS OF LOW AND HIGH-DOSES OF REPEATED ORAL DEXFENFLURAMINE IN RATS - A COMPARISON WITH FLUOXETINE, Pharmacology, biochemistry and behavior, 57(4), 1997, pp. 851-856

DRUG DEVELOPMENT - RESPONSE

Authors: GARATTINI S

Citation: S. Garattini, DRUG DEVELOPMENT - RESPONSE, Science, 277(5322), 1997, pp. 20-20

FINANCIAL INTERESTS CONSTRAIN DRUG DEVELOPMENT

Authors: GARATTINI S

Citation: S. Garattini, FINANCIAL INTERESTS CONSTRAIN DRUG DEVELOPMENT, Science, 275(5298), 1997, pp. 287-287

A PROSPECTIVE EPIDEMIOLOGIC SURVEY OF THE NATURAL-HISTORY OF CHRONIC CRITICAL LEG ISCHEMIA

Authors: BELGRANO EA NARDELLA L PONZIO F NESSI F GUALA A MAZZUCCHETTI S GRAZIANO L URBAN I PALOMBO D BRUSTIA P CALZONI D BELLONE M ALTIERI M AGUS GB DEANGELIS R MARROCU R GROSSI A FRIGERIO D BIASI GM PIGLIONICA MR AGRIFOGLIO G COSTANTINI A DELLAVEDOVA MR MIGLIERINA L LAVORATO F EMANUELLI G ROSSI R FLANDOLI C PONTI GB BERRA S LOSAPIO GM INZOLI MR LOMBARDI G TARANTOLA P ZOCCA N SFORZA M RUSSO R TENCHINI P BRUNI T FONTANILI M GUIDETTI D ODERO A SALVINI M PEDEFERRI G BORDONI MC VEDOVATO F BITTOLO BG MAFFEI L MARCON G DELLOLIVO I GRACCO L PETRALIA G CORDIANO C DORUCCI V PAGNAN A VISONA A TONIETTO G AGRESTA F FAVRETTI F BURIGO E GIANSANTE C FIOTTI N PAMICH G SANTIROCCO C MOZZON L GONANO N PETRILLI GL PUZZO A BALDINOG G PODESTA A GUASTINI A TRAVERSARO A ZINICOLA N BAGLIETTO F BORGATTI E FILIPPINI M FERRARI F COPPI G CAMPARINI S TUSCANO G LONARDI R BOTTA GC BANCHINI E PAVARINI E DELMONTE E BUCHERINI E MORATTI A IERAN M BERTINI D PRATESI C CORSI C POLLASTRI M MARRAPODI E VANNI D RALLI L CECCHI M BIGALLI A DELCARRATORE G MOSCA F VATTERONI F SETACCI C CAO P VERZINI F MANNARINO E PASQUALINI L FEDELI F ALO F IOANNIDIS G SPARTERA C MARINO G MEDORI M POLA P DALLAGO AA DIGIOVANANI V COLLI R MANISCALCO G BARTOLO M TODINI AR BENEDETTIVALENTINI F IRACE L FIORANI P TAURINO M MARCIALIS A VALITUTTI P VIGLIOTTI G REGINA G FULLONE M RIZZO S ROLLI F PASCALI M LUCENTINI L GRILLI M CORRERA H FLORENA M CASSINA I NOTARBARTOLO A BELVEDERE M ANDREOZZI GM DIPINO L MARTINI R SIGNORELLI S CAVALLARO S PULEO R ROMEO S CORMACI OF COSTANZO C GRASSO A AVANZINI F BEDONI P BERTELE V COLOMBO F FELLIN G PANGRAZZI J RONCAGLIONI MC SAMORI G TOGNONI G DEGAETANO G GARATTINI S

Citation: Ea. Belgrano et al., A PROSPECTIVE EPIDEMIOLOGIC SURVEY OF THE NATURAL-HISTORY OF CHRONIC CRITICAL LEG ISCHEMIA, European journal of vascular and endovascular surgery, 11(1), 1996, pp. 112-120

LOW-DOSE NEUROLEPTIC THERAPY AND RELAPSE IN SCHIZOPHRENIA - METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Authors: BARBUI C SARACENO B LIBERATI A GARATTINI S

Citation: C. Barbui et al., LOW-DOSE NEUROLEPTIC THERAPY AND RELAPSE IN SCHIZOPHRENIA - METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS, European psychiatry, 11(6), 1996, pp. 306-313

6-MONTH EFFECTS OF EARLY TREATMENT WITH LISINOPRIL AND TRANSDERMAL GLYCERYL TRINITRATE SINGLY AND TOGETHER WITHDRAWN 6 WEEKS AFTER ACUTE MYOCARDIAL-INFARCTION - THE GISSI-3 TRIAL

Authors: DEVITA C FAZZINI PF GERACI E TAVAZZI L TOGNONI G VECCHIO C BOERI R DAMICO G LOI U MARUBINI E PAGLIARO L ROVELLI F FRANZOSI MG LATINI R MAGGIONI AP MAURI F VOLPI A BARLERA S NEGRI E NICOLIS E SANTORO E SANTORO L ASCIONE A BONFANTI E CAPELLO T CASATI A CORATO A GARDINALE E NEGRINI M NOBILI A STASZEWSKY L TAVANELLI M TORTA D ZUANETTI G GAMBELLI G MORONI L PELLANDA JJ PIETROPAOLO F BALLI E BARBIERI A BECHI S CARRONE M CATANZARO M FASCIOLO L FRESCO C GHIANI A IACUITTI G LEDDA A LEVANTESI G MORONI L PASINI P PECI P PIZZETTI F SAGONE A TURAZZA F VILLELLA A VILLELLA M BRAGGIO N DISERTORI M FREZZATI S GARATTINI S MARINO P MASERI A MAZZOTTA G NICOLOSI G PIRELLI S SANNA GP VALAGUSSA F DARGIE HJ PETO R POCOCK S SLEIGHT P YUSUF S

Citation: C. Devita et al., 6-MONTH EFFECTS OF EARLY TREATMENT WITH LISINOPRIL AND TRANSDERMAL GLYCERYL TRINITRATE SINGLY AND TOGETHER WITHDRAWN 6 WEEKS AFTER ACUTE MYOCARDIAL-INFARCTION - THE GISSI-3 TRIAL, Journal of the American College of Cardiology, 27(2), 1996, pp. 337-344

A PHARMACOLOGISTS PRESCRIPTION

Authors: FOX R GARATTINI S

Citation: R. Fox et S. Garattini, A PHARMACOLOGISTS PRESCRIPTION, Lancet, 348(9021), 1996, pp. 172-174

CUMBERSOME COMPROMISE FOR ORGAN DONATION IN ITALY

Authors: GARATTINI S

Citation: S. Garattini, CUMBERSOME COMPROMISE FOR ORGAN DONATION IN ITALY, Lancet, 347(9000), 1996, pp. 531-531

PHARMACOLOGY OF INGESTIVE BEHAVIOR

Authors: SAMANIN R GARATTINI S

Citation: R. Samanin et S. Garattini, PHARMACOLOGY OF INGESTIVE BEHAVIOR, Therapie, 51(2), 1996, pp. 107-115

IN-VITRO AND IN-VIVO EFFECTS OF THE ANORECTIC AGENT DEXFENFLURAMINE ON THE CENTRAL SEROTONINERGIC NEURONAL SYSTEMS OF NONHUMAN-PRIMATES - ACOMPARISON WITH THE RAT

Authors: MENNINI T FRACASSO C CAGNOTTO A BERGAMI A FRITTOLI E GOBBI M CACCIA S GARATTINI S

Citation: T. Mennini et al., IN-VITRO AND IN-VIVO EFFECTS OF THE ANORECTIC AGENT DEXFENFLURAMINE ON THE CENTRAL SEROTONINERGIC NEURONAL SYSTEMS OF NONHUMAN-PRIMATES - ACOMPARISON WITH THE RAT, Naunyn-Schmiedeberg's archives of pharmacology, 353(6), 1996, pp. 641-647

MECHANISM OF INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION BY CHLORPROMAZINE AND ITS DERIVATIVES IN MICE

Authors: GHEZZI P GARATTINI S MENNINI T BERTINI R HERNANDEZ RD BENIGNI F SACCO S SKORUPSKA M MENGOZZI M LATINI R KUROSAKI M LOMBET A FRADIN A BONNET J ROLLAND Y BRION JD

Citation: P. Ghezzi et al., MECHANISM OF INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION BY CHLORPROMAZINE AND ITS DERIVATIVES IN MICE, European journal of pharmacology, 317(2-3), 1996, pp. 369-376

RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS

Authors: DOUGADOS M DEVOGELAER JP ANNEFELDT M AVOUAC B BOUVENOT G COOPER C DIEPPE P ETHGEN D GARATTINI S JONES EA KAUFMAN JM LEEMING M LEMMEL EM LOHMANDER S MENKES CJ NUKI G PAOLOZZI L PUJOL JP ROVATI L SERNI U SPECTOR T TSOUDEROS Y VEYS EM WESELOH G REGINSTER JY

Citation: M. Dougados et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS, Annals of the Rheumatic Diseases, 55(8), 1996, pp. 552-557

EFFECT OF D-FENFLURAMINE ON THE INDOLE CONTENTS OF THE RAT-BRAIN AFTER TREATMENT WITH DIFFERENT INDUCERS OF CYTOCHROME-P450 ISOENZYMES

Authors: ANELLI M FRACASSO C BERGAMI A FERRARESE A GARATTINI S CACCIA S

Citation: M. Anelli et al., EFFECT OF D-FENFLURAMINE ON THE INDOLE CONTENTS OF THE RAT-BRAIN AFTER TREATMENT WITH DIFFERENT INDUCERS OF CYTOCHROME-P450 ISOENZYMES, Psychopharmacology, 118(2), 1995, pp. 188-194

Risultati: 1-25 | 26-47